Daiwa Securities Group’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2K | Hold |
218
| – | – | ﹤0.01% | 1207 |
|
|
2025
Q1 | $2K | Hold |
218
| – | – | ﹤0.01% | 1177 |
|
|
2024
Q4 | $3K | Hold |
218
| – | – | ﹤0.01% | 1188 |
|
|
2024
Q3 | $4K | Hold |
218
| – | – | ﹤0.01% | 1178 |
|
|
2024
Q2 | $4K | Buy |
218
+91
| +72% | +$1.67K | ﹤0.01% | 1200 |
|
|
2024
Q1 | $2K | Hold |
127
| – | – | ﹤0.01% | 1255 |
|
|
2023
Q4 | $1K | Hold |
127
| – | – | ﹤0.01% | 1282 |
|
|
2023
Q3 | $1K | Hold |
127
| – | – | ﹤0.01% | 1234 |
|
|
2023
Q2 | $1K | Hold |
127
| – | – | ﹤0.01% | 1253 |
|
|
2023
Q1 | $1K | Hold |
127
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q4 | $1K | Hold |
127
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q3 | $2K | Hold |
127
| – | – | ﹤0.01% | 1210 |
|
|
2022
Q2 | $2K | Hold |
127
| – | – | ﹤0.01% | 1215 |
|
|
2022
Q1 | $1K | Hold |
127
| – | – | ﹤0.01% | 1289 |
|
|
2021
Q4 | $2K | Buy |
+127
| New | +$2K | ﹤0.01% | 1268 |
|